Tender Description:
Item Description: srph153049-coronary drug eluting stents (1) single wire technology on cob alt based alloy platform (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) ste nt diameter should be from 2.25 mm to 4 mm and length of the stent from 12mm to 38 mm . (4) the strut thickness should be 81 micron or less. (5) stent delivery system should b e monorail (single operator exchange or rapid exchange). (6) stent should be compati ble with 5fr guiding catheter (7) stent design should be open cell type. (8) stent shoul d be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid . (9) five years long term efficacy and safety of the stent in terms of target vessel re vascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals.(10) the documents pertaining to the efficacy and s afety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. unit:no
Dates:
Published on
June 24, 2024, 6:20 p.m.
Bid Opening Date
July 9, 2024, 4 p.m.
Doc Download started
June 24, 2024, 6:20 p.m.
Doc Download ended
July 9, 2024, 4 p.m.